Skip Navigation


Human Reproduction Update Advance Access originally published online on May 26, 2005
Human Reproduction Update 2005 11(4):391-410; doi:10.1093/humupd/dmi012
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
11/4/391    most recent
dmi012v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (55)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Goswami, D.
Right arrow Articles by Conway, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goswami, D.
Right arrow Articles by Conway, G. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions{at}oupjournals.org

Premature ovarian failure

Deepti Goswami and Gerard S. Conway1

Department of Endocrinology, The Middlesex Hospital, London W1T 3AA, UK

1 To whom correspondence should be addressed. Email: g.conway{at}ucl.ac.uk

Premature ovarian failure (POF) causing hypergonadotrophic hypogonadism occurs in 1% of women. In majority of cases the underlying cause is not identified. The known causes include: (a) Genetic aberrations, which could involve the X chromosome or autosomes. A large number of genes have been screened as candidates for causing POF; however, few clear causal mutations have been identified. (b) Autoimmune ovarian damage, as suggested by the observed association of POF with other autoimmune disorders. Anti-ovarian antibodies are reported in POF by several studies, but their specificity and pathogenic role are questionable. (c) Iatrogenic following surgical, radiotherapeutic or chemotherapeutic interventions as in malignancies. (d) Environmental factors like viral infections and toxins for whom no clear mechanism is known. The diagnosis is based on finding of amenorrhoea before age 40 associated with FSH levels in the menopausal range. Screening for associated autoimmune disorders and karyotyping, particularly in early onset disease, constitute part of the diagnostic work-up. There is no role of ovarian biopsy or ultrasound in making the diagnosis. Management essentially involves hormone replacement and infertility treatment, the only proven means for the latter being assisted conception with donated oocytes. Embryo cryopreservation, ovarian tissue cryopreservation and oocyte cryopreservation hold promise in cases where ovarian failure is foreseeable as in women undergoing cancer treatments.

Key words: autoimmune ovarian damage / environmental factors / genetic aberrations / hormone replacement / premature ovarian failure


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
R.A. Oldenburg, M.F. van Dooren, B. de Graaf, E. Simons, L. Govaerts, S. Swagemakers, J.M.H. Verkerk, B.A. Oostra, and A.M. Bertoli-Avella
A genome-wide linkage scan in a Dutch family identifies a premature ovarian failure susceptibility locus
Hum. Reprod., August 9, 2008; (2008) den278v1.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S.J. Silber, M. DeRosa, J. Pineda, K. Lenahan, D. Grenia, K. Gorman, and R.G. Gosden
A series of monozygotic twins discordant for ovarian failure: ovary transplantation (cortical versus microvascular) and cryopreservation
Hum. Reprod., July 1, 2008; 23(7): 1531 - 1537.
[Abstract] [Full Text] [PDF]

Home page
 Ann Clin BiochemHome page
S. Mehta and T. Wang
Intermittent ovarian and thyroid failure and spontaneous twin pregnancy
Ann Clin Biochem, May 1, 2008; 45(3): 331 - 334.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Huser, I. Crha, P. Ventruba, R. Hudecek, J. Zakova, L. Smardova, Z. Kral, and J. Jarkovsky
Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients
Hum. Reprod., April 1, 2008; 23(4): 863 - 868.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. H. Yoon, Y. M. Choi, M. A. Hong, B. M. Kang, J. J. Kim, E. G. Min, J. G. Kim, and S. Y. Moon
X chromosome inactivation patterns in patients with idiopathic premature ovarian failure
Hum. Reprod., March 1, 2008; 23(3): 688 - 692.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
G. Tachdjian, A. Aboura, M.-F. Portnoi, M. Pasquier, N. Bourcigaux, T. Simon, G. Rousseau, L. Finkel, M. Benkhalifa, and S. Christin-Maitre
Cryptic Xp duplication including the SHOX gene in a woman with 46,X, del(X)(q21.31) and premature ovarian failure
Hum. Reprod., January 1, 2008; 23(1): 222 - 226.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R.G. Gosden, S.A. Treloar, N.G. Martin, L.F. Cherkas, T.D. Spector, M.J. Faddy, and S.J. Silber
Prevalence of premature ovarian failure in monozygotic and dizygotic twins
Hum. Reprod., February 1, 2007; 22(2): 610 - 615.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. T. Pagnamenta, J.-W. Taanman, C. J. Wilson, N. E. Anderson, R. Marotta, A. J. Duncan, M. B. Glindzicz, R. W. Taylor, A. Laskowski, D. R. Thorburn, et al.
Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma
Hum. Reprod., October 1, 2006; 21(10): 2467 - 2473.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M.F. Portnoi, A. Aboura, G. Tachdjian, P. Bouchard, D. Dewailly, N. Bourcigaux, R. Frydman, A.-C. Reyss, S. Brisset, and S. Christin-Maitre
Molecular cytogenetic studies of Xq critical regions in premature ovarian failure patients
Hum. Reprod., September 1, 2006; 21(9): 2329 - 2334.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
F. Rizzolio, S. Bione, C. Sala, M. Goegan, M. Gentile, G. Gregato, E. Rossi, T. Pramparo, O. Zuffardi, and D. Toniolo
Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature
Hum. Reprod., June 1, 2006; 21(6): 1477 - 1483.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
P. Laissue, S. Christin-Maitre, P. Touraine, F. Kuttenn, O. Ritvos, K. Aittomaki, N. Bourcigaux, L. Jacquesson, P. Bouchard, R. Frydman, et al.
Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure.
Eur. J. Endocrinol., May 1, 2006; 154(5): 739 - 744.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. C. Layman
BMP15--The First True Ovarian Determinant Gene on the X-Chromosome?
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1673 - 1676.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Di Pasquale, R. Rossetti, A. Marozzi, B. Bodega, S. Borgato, L. Cavallo, S. Einaudi, G. Radetti, G. Russo, M. Sacco, et al.
Identification of New Variants of Human BMP15 Gene in a Large Cohort of Women with Premature Ovarian Failure
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1976 - 1979.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.